Bluewind Medical announced the successful completion of patient enrollment in the OASIS pivotal clinical study that will be the basis by which the company will seek US-FDA (Food & Drug Administration) marketing clearance in the United States. OASIS is a 150-patient prospective clinical study designed to demonstrate the safety and efficacy of Bluewind Medical’s RENOVA […]
Statement from Senator Orrin G. Hatch: Drug Pricing Provisions in Infrastructure Bill Could Undermine Hatch-Waxman
Introducing a New Approach to Diagnose and Treat Cancer. NuView Life Sciences, Inc established NuView LATAM in Mexico City.
nView announces the 510(k) clearance of the nView s1 with navigation option by the FDA along with AI-enabled image analysis and 3D stitching
Solid quarterly results highlighted by record revenue of $30.1 million, pre-tax income of $13.6 million and fully diluted EPS of $0.38
The Utah legislature convened in special session this week regarding the issuance of an OSHA Emergency Temporary Standard (ETS) requiring the vaccination of all employees of companies with more than 100 employees.
AdvaMed released a statement from AdvaMedDx Executive Director Susan Van Meter on the testing policy regulation recently proposed by the Occupational Safety and Health Administration (OSHA) for employers with 100 or more employees under the Administration’s vaccine mandate.
PolarityTE, Inc. recently provided a business update and reported financial results for the three and nine-month periods ended September 30, 2021.
Leading clinicians discuss enabling long-term kidney health in Veterans with type 2 diabetes and early-stage chronic kidney disease
Partnership expands doctor and patient access to advanced prognosis and coordinated care management of early-stage diabetic kidney disease
Company’s validated test available in the UK following implementation of UKHSA CTDA Regulations
PhRMA released a new report detailing the more than 260 medicines in development for 29 neurodegenerative diseases